F Ziemssen, M Warga, IM Neuhann, M Leitritz, … - British Medical Journal, 2006 - bjo.bmj.com We conclude that metastatic disease should be considered in the differential
diagnosis of eyelid lesions. The present case emphasises the need for a good
medical history in cases of persistent eyelid swelling. Even in the case of ... Cited by 10 - Related articles - All 6 versions
SR Hannan, KC Madhusudhana, AJ Lotery, … - British Medical Journal, 2007 - bjo.bmj.com Retinal pigment epithelium (RPE) tears are an uncommon but visually damaging
complication of pigment epithelial detachment (PED), caused by weak atrophic
margins of chronic PED and contraction of sub-RPE fibrovascular scar ... Cited by 3 - Related articles - All 6 versions
JB Jonas, UH Spandau, F Rensch, S Von Baltz … - Journal of Ocular Pharmacology and Therapeutics, 2007 - liebertonline.com Aims: The aim of this study was to evaluate the rate of infectious and
noninfectious en- dophthalmitis after an intravitreal injection of bevacizumab.
Methods: This clinical interventional case-series study included 1218 ... Cited by 18 - Related articles - BL Direct - All 4 versions
R Scartozzi, JR Chao, AC Walsh, D Eliott - Eye (London, England), 2008 - ncbi.nlm.nih.gov 1: Eye. 2008 Jun 6. [Epub ahead of print]. Bilateral improvement of persistent
diffuse diabetic macular oedema after unilateral intravitreal ... Cited by 4 - Related articles - All 3 versions
- ►duanesolution.com C Kiss, S Michels, F Prager, GN Weigert, W … - Retina, 2006 - journals.lww.com From the Department of Ophthalmology and Optometry, Med- ical University of
Vienna, Vienna, Austria. Reprint requests: Stephan Michels, MD, Department of
Ophthal- mology and Optometry, Medical University of Vienna, Waehringer ... Cited by 33 - Related articles - BL Direct - All 4 versions
J Levy, M Shneck, S Rosen, I Klemperer, D … - International Ophthalmology, 2009 - Springer Abstract Objective To report the visual and anatomic outcome of intravitreal
bevacizumab (Avastin) injec- tions in the treatment of subfoveal neovascular
age-related macular degeneration (AMD). Methods Interventional, ... Cited by 5 - Related articles - All 2 versions
JM Mones, MA Lopez, JA Prieto, JP … - Ophthalmic surgery, lasers & imaging: the official … - ncbi.nlm.nih.gov Considering the risk of recurrence of extrafoveal or juxtafoveal lesions after
thermal laser treatment and the risk of poor response to photodynamic therapy,
it seems reasonable to discuss with the patient the risks and benefits of ... Cited by 7 - Related articles - BL Direct - All 3 versions
ML Abrahám-Marin, CF Cortés-Luna, G … - Graefe's Archive for Clinical and Experimental …, 2007 - Springer Abstract Purpose To evaluate the efficacy and safety of intravitreal bevacizumab
therapy for neovascular age-related macular degeneration (ARMD). Methods
Patients with diagnosis of neovascular ARMD without any other ocular ... Cited by 33 - Related articles - BL Direct - All 3 versions
- ►nih.gov M Lüke, M Warga, F Ziemssen, F Gelisken, S … - British Journal of Ophthalmology, 2006 - bjo.bmj.com Background: Bevacizumab (Avastin) is a recombinant protein that targets vascular
endothelial growth factor (VEGF). In vitro, bevacizumab inhibits VEGF induced
cell proliferation and tissue factor production. Abnormal angiogenesis ... Cited by 35 - Related articles - BL Direct - All 7 versions
